Greater surgeon experience increases likelihood of mitral valve repair vs. replacement

April 30, 2014

A new study presenting data from 17 cardiac surgical centers in Virginia, representing 100 surgeons and 99% of cardiac operations performed in the state, demonstrates that, even today, significant variations – among surgeons and hospitals - still exist in the performance of mitral valve repair vs replacement for moderate to severe mitral regurgitation. Significant associations were observed between the propensity for MV repair and both institutional and surgeon annual volume, although increasing surgeon volume appears to be the much stronger predictor.

Damien J. LaPar, MD, MSc, of the Division of Thoracic and Cardiovascular Surgery at the University of Virginia (Charlottesville), is presenting the results of this research at the 94th AATS Annual Meeting in Toronto, ON, Canada on April 30, 2014.

When the mitral valve (MV) leaks, blood can flow backward or "regurgitate" into the upper heart chamber, leading to decreased blood flow to the rest of the body. To compensate, the heart may try to pump harder, and this can result in congestive heart failure. When regurgitation is severe, the standard of care treatment is MV surgery. Two options are available: mitral value repair or replacement.

Professional associations such as the American College of Cardiology and the American Heart Association recommend mitral valve surgery over medical management for severe . Yet, only 50% of patients meeting the ACC/AHA guidelines for surgical treatment undergo surgery. Furthermore, while MV repair is associated with superior perioperative outcomes and reduced mortality compared to replacement, it appears to be underutilized.

In this large, multi-institutional retrospective study from the Virginia Cardiac Surgery Quality Initiative, more than 4,000 patients were evaluated, and 60% underwent MV repair. Significant variations were seen in MV repair rates among hospitals (35-70% of MV procedures) and (0-90%).

The results suggest that what type of a patient received depended in part on how experienced the surgeon was. After adjustment for baseline preoperative patient risk, when the propensity to perform an MV repair was plotted against surgeon volume, it became apparent that there was an "inflection point" of increased probability for mitral repair when the average annual surgeon volume (a surrogate for surgeon experience) exceeded approximately 20 surgeries a year. Surgeons who performed more than 20 MV surgeries a year were between 3 and 4 times more likely to perform a repair than replacement compared to those who operated less than 20 times a year.

Dr. LaPar suggests that the results may have important future implications on patient referral of care and quality measure assessment. "In the upcoming era of percutaneous MV repair technology, surgeon volume and expertise as a gatekeeper should dictate access to this technology and the decisions for approach to MV repair."

Explore further: Study: New heart valve repair option provides hope for high-risk patients

More information: "Mitral valve repair rates correlate with surgeon and institutional experience," by Damien J. LaPar, MD, MSc, Gorav Ailawadi, MD, James Isbell, MD, MSc, Ivan K. Crosby, MD, John A. Kern, MD, Jeffrey B. Rich, MD, Alan M. Speir, MD, Irving L. Kron, MD. Presentation at the 94th AATS Annual Meeting. April 26-30, 2014, Toronto, ON, Canada during the Adult Cardiac Surgery Session on April 30, 8:04 AM ET.

Related Stories

Recommended for you

International study proves old blood is as good as new

October 24, 2016

It's been long thought that when blood transfusions are needed, it may be best to use the freshest blood, but McMaster University researchers have led a large international study proving that it is not so.

Study finds mixed results for use of mesh for hernia repair

October 18, 2016

Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term ...

Traditional surgery style worthwhile, says piles trial

October 10, 2016

Results of a five year trial on haemorrhoids (commonly known as piles), jointly sponsored by NHS Highland and the University of Aberdeen, have this week been published in The Lancet, one of the world's oldest and best known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.